Soluble interleukin-2 receptor, interleukin-6 and interleukin-1 beta in patients with Crohn's disease and ulcerative colitis: preoperative levels and postoperative changes of serum concentrations.

Letter: Serum lysozyme levels in Crohn's disease and ulcerative colitis.

Serum lysozyme levels in Crohn's disease and ulcerative colitis.

Preoperative Corticosteroid Usage and Hypoalbuminemia Increase Occurrence of Short-term Postoperative Complications in Chinese Patients with Ulcerative Colitis.

Reduced total serum bilirubin levels are associated with ulcerative colitis.

Raised serum soluble interleukin-2 receptor concentrations in cystic fibrosis patients with and without evidence of lung disease.

Circulating memory B cells and plasmablasts are associated with the levels of serum immunoglobulin in patients with ulcerative colitis.

Ulcerative colitis and Crohn's disease.

Postoperative changes of manometry after restorative proctocolectomy in Korean ulcerative colitis patients.

Ménétrier Disease and Ulcerative Colitis.

Prior response to infliximab and early serum drug concentrations predict effects of adalimumab in ulcerative colitis.

Serum Soluble (Pro)Renin Receptor Levels in Maintenance Hemodialysis Patients.

Immunological studies in ulcerative colitis. VIII. Antibodies to colon antigen in patients with ulcerative colitis, Crohn's disease, and other diseases.

Soluble interleukin-2 receptor α and interleukin-2 serum levels in patients with basal cell carcinoma.

Cytomegalovirus infection and postoperative complications in patients with ulcerative colitis undergoing colectomy.

Increased levels of beta 2-microglobulin, soluble interleukin-2 receptor, and soluble CD8 in patients with subacute sclerosing panencephalitis.

HLA-DR, DQ and T cell antigen receptor constant beta genes in Japanese patients with ulcerative colitis.

Increased concentrations of soluble interleukin-2 receptor in the serum of patients with systemic sclerosis.

Increased serum levels of interleukin-2 and soluble interleukin-2 receptor in celiac disease.

Soluble interleukin-2 receptor and soluble CD8 antigen levels in serum from patients with non-resectable lung cancer.

Soluble interleukin-2 receptor in Crohn's disease: relation of serum concentrations to disease activity.

Association between serum concentration of infliximab and efficacy in adult patients with ulcerative colitis.

Assessing disease activity in patients with ulcerative colitis.

Global mucosal and serum cytokine profile in patients with ulcerative colitis undergoing anti-TNF therapy.

Serum soluble CD4 and CD8 levels in Kawasaki disease.

Suggest Documents

Letter: Serum lysozyme levels in Crohn's disease and ulcerative colitis.

Serum lysozyme levels in Crohn's disease and ulcerative colitis.

Preoperative Corticosteroid Usage and Hypoalbuminemia Increase Occurrence of Short-term Postoperative Complications in Chinese Patients with Ulcerative Colitis.

Reduced total serum bilirubin levels are associated with ulcerative colitis.

Raised serum soluble interleukin-2 receptor concentrations in cystic fibrosis patients with and without evidence of lung disease.

Circulating memory B cells and plasmablasts are associated with the levels of serum immunoglobulin in patients with ulcerative colitis.

Ulcerative colitis and Crohn's disease.

Postoperative changes of manometry after restorative proctocolectomy in Korean ulcerative colitis patients.

Ménétrier Disease and Ulcerative Colitis.

Prior response to infliximab and early serum drug concentrations predict effects of adalimumab in ulcerative colitis.

Serum Soluble (Pro)Renin Receptor Levels in Maintenance Hemodialysis Patients.

Immunological studies in ulcerative colitis. VIII. Antibodies to colon antigen in patients with ulcerative colitis, Crohn's disease, and other diseases.

Soluble interleukin-2 receptor α and interleukin-2 serum levels in patients with basal cell carcinoma.

Cytomegalovirus infection and postoperative complications in patients with ulcerative colitis undergoing colectomy.

Increased levels of beta 2-microglobulin, soluble interleukin-2 receptor, and soluble CD8 in patients with subacute sclerosing panencephalitis.

HLA-DR, DQ and T cell antigen receptor constant beta genes in Japanese patients with ulcerative colitis.

Increased concentrations of soluble interleukin-2 receptor in the serum of patients with systemic sclerosis.

Increased serum levels of interleukin-2 and soluble interleukin-2 receptor in celiac disease.

Soluble interleukin-2 receptor and soluble CD8 antigen levels in serum from patients with non-resectable lung cancer.

Soluble interleukin-2 receptor in Crohn's disease: relation of serum concentrations to disease activity.

Association between serum concentration of infliximab and efficacy in adult patients with ulcerative colitis.

Assessing disease activity in patients with ulcerative colitis.

Global mucosal and serum cytokine profile in patients with ulcerative colitis undergoing anti-TNF therapy.

Serum soluble CD4 and CD8 levels in Kawasaki disease.

Soluble interleukin-2 receptor, interleukin-6 and interleukin-1 beta in patients with Crohn's disease and ulcerative colitis: preoperative levels and postoperative changes of serum concentrations.

Recommend Documents

Follow Us